Dr. Mathew's publications on Michigan Research Experts

Dr. Mathew's publications on PubMed

Dr. Mathew's publications on ORCID and Google scholars

Select Publications

1. Mathew AV, Li L, Byun J, Guo Y, Michailidis G, Jaiswal M, Chen YE, Pop-Busui R, Pennathur S. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes care. 2018; 41(11):2431-2437. PMID: 30201848, PMCID: PMC6196832

2. Zeng L, Mathew AV, Byun J, Atkins KB, Brosius FC 3rd, Pennathur S. Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis. The Journal of biological chemistry. 2018; 293(19):7238-7249. PMID: 29581235, PMCID: PMC5949994

3. Mathew AV, Zeng L, Byun J, Pennathur S. Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis. Journal of proteomics & bioinformatics. 2015; Suppl 14. NIHMSID: NIHMS735560 PMID: 26778898, PMCID: PMC4712927

4. Konje VC, Rajendiran TM, Bellovich K, Gadegbeku CA, Gipson DS, Afshinnia F, Mathew AV. Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease. Clin Kidney J. 2021 Apr;14(4):1097-1105. doi: 10.1093/ckj/sfaa031. eCollection 2021 Apr. PubMed PMID: 34094518; PubMed Central PMCID: PMC8173620.

5. Benitez T, VanDerWoude E, Han Y, Byun J, Konje VC, Gillespie BW, Saran R, Mathew AV. Kynurenine Pathway Metabolites Predict Subclinical Atherosclerotic Disease and New Cardiovascular Events in Chronic Kidney Disease. Clinical Kidney Journal.